MedTrace Logo

Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes

NCT02869113 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2018-12-12

No results posted yet for this study

Summary

The objective of this study was to compare the human eye stinging potential of experimental formulas and an industry standard shampoo mixture. The study was conducted under the supervision of a Board Certified Ophthalmologist.

Conditions

  • Sunscreen Agents

Interventions

DRUG

BAY98751 (Y65-110)

10 µL in one eye

DRUG

BAY 98751 (Y65-102)

10 µL in one eye

DRUG

BAY 98751 (Y65-106)

10 µL in one eye

DRUG

Standard shampoo mixture (Control)

10 µL in other eye

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-23
Primary Completion
2015-01-24
Completion
2015-01-24

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02869113 on ClinicalTrials.gov